My name is Ming Valerie Lin. I earned my medical degree from the University of KwaZulu-Natal in Durban, South Africa, before completing a one-year internship at Groote Schuur Hospital, University of Cape Town. I subsequently relocated to the United States to pursue an Internal Medicine Residency at Pennsylvania Hospital, affiliated with the University of Pennsylvania Health System (Penn Medicine). After completing my residency, I undertook a fellowship in Gastroenterology at the University of Cincinnati, followed by an Advanced/Transplant Hepatology fellowship at Massachusetts General Hospital. I currently serve as a transplant hepatologist and gastroenterologist at Lahey Hospital & Medical Center. Additionally, I am the Medical Director of the Liver Tumor Program and the Associate Program Director of the Advanced/Transplant Hepatology Fellowship. I hold the position of Assistant Professor in the Department of Medicine at the University of Massachusetts Chan-Lahey Medical School and am an Adjunct Assistant Professor in the Department of Medicine at Tufts University School of Medicine. My research has primarily focused on gastroenterology, hepatology, and liver transplantation. During my medical training, I participated in an NIH-funded project examining hepatitis C viral mutations in hemophiliacs with HIV/HCV co-infection. I also served as a Principal Investigator for the Bristol-Myers Squibb Virology Fellow Research Program, where I evaluated the use of high-resolution melting (HRM) analysis for detecting IL28B rs12979860 polymorphisms in HCV-infected patients. These efforts led to multiple peer-reviewed publications and contributions to book chapters. In 2018, I joined Lahey Hospital & Medical Center, where my research focus shifted to cirrhosis and frailty. This interest stemmed from clinical observations of poor outcomes in patients with cirrhosis and frailty, both pre- and post-liver transplant, and a lack of robust literature and guidelines in this area. In recognition of my potential contributions, I was awarded the Robert E. Wise Educational and Research Grant in 2019. This funding has supported my ongoing work in developing and evaluating the Telemedicine-Assisted Prehabilitation (TAP) program for patients with decompensated cirrhosis. Despite challenges posed by the COVID-19 pandemic, I successfully completed the pilot phase, which involved 11 patients, and am currently progressing toward the final phase of the program. In addition to the TAP program, I have developed the Liver Frailty and Prehabilitation Clinical Protocol and established the Liver Frailty Program within our division. I have been invited to share my expertise on frailty and cirrhosis through peer-reviewed journal commentaries, book chapters, and presentations at regional and national meetings. I am also collaborating with anesthesiologists and transplant surgeons on a project evaluating early extubation and survival outcomes in liver transplantation, with the goal of optimizing post-transplant recovery and reducing healthcare utilization. This research has been accepted for presentation at the Digestive Disease Week (American Gastroenterology Association) in May 2025, and a manuscript has recently been submitted to Liver Transplantation. Additionally, using data from our center’s liver transplant registry, I am developing proposals to assess post-liver transplant outcomes in cirrhotic patients with obesity versus those with non-obesity sarcopenia/frailty. As Principal Investigator for Lahey Hospital & Medical Center within the Multi-organ Dysfunction and Evaluation for Liver Transplantation (MODEL) consortium, I have contributed to multiple research studies, leading to manuscript publications and presentations at national conferences. I was also invited to participate in a video interview with Clinical Liver Disease discussing post-transplant complications in the context of acute-on-chronic liver failure and immunosuppression considerations. In my role as Medical Director of the Liver Tumor Program, I have developed transplant oncology protocols for intrahepatic cholangiocarcinoma, metastatic neuroendocrine tumors, and colorectal liver metastasis. I have also updated our existing liver transplant protocols for hepatocellular carcinoma, perihilar cholangiocarcinoma and post-liver transplant immunosuppression management in transplant oncology patient population. I am collaborating with our internal medicine residents on projects assessing the impact of complete tumor necrosis on post-transplant cancer recurrence and the correlation between radiological treatment responses and histological tumor outcomes. Additionally, I am working with oncology colleagues to evaluate the risk of MSI-H cancers in post-liver transplant patients. I have served as an ad hoc reviewer for nine different journals since my GI fellowship in 2010, reviewing over 20-30 articles. These journals include Gastroenterology Hepatology Advances, Transplantation, World Journal of Gastroenterology, Digestive Disease and Sciences Journal, Therapeutic Advances in Gastroenterology, and Journal of General Internal Medicine. I recently published a commentary titled “Frailty in liver transplant recipients: A serious issue that would benefit from a redefinition of 'successful' intervention” in Transplantation. These experiences have equipped me with the skills necessary to contribute meaningfully as an Editorial Board member for the World Journal of Hepatology. Throughout my career, I have come to value the importance of clear communication within multidisciplinary teams and the need for well-constructed research plans with realistic timelines and budgets. My role as Medical Director of the Liver Tumor Program has also allowed me to expand my expertise in transplant oncology, a field that has become a personal passion. I am confident that my clinical training, research experience, leadership abilities, and collaborative spirit make me well-suited to contribute to the Editorial Board of the World Journal of Hepatology. In my personal time, I enjoy staying active and spending time outdoors with my family. I engage in activities such as traveling, hiking, swimming, cycling, and playing competitive badminton.